Related Experiment Video
Updated: Jan 23, 2026

Robotic Ablation of Atrial Fibrillation
Published on: May 29, 2015
Security profile of direct anticoagulants. Preferred use in atrial fibrillation
Inmaculada Roldán Rabadán1, María Alonso de Leciñana2, Raquel Barba Martín3
1Servicio Cardiología, Hospital Universitario La Paz, CIBER-CV, Madrid, España.
Abstract:
A multidisciplinary panel of cardiologists, neurologists, internal medicine and specialists in hemostasis and thrombosis has elaborated this document showing recent scientific evidences supporting a better profile of direct oral anticoagulants (DOACs) versus vitaminK antagonists (VKA), as well as the indications of specific antidotes and hemostatic agents to reverse the anticoagulant effects of DOACs. The analysis reinforces the best profile of DOACs and its special benefit in patients with basal high hemorrhagic risk.
Related Concept Videos
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid Fibrils
Fibril-associated Collagen
For example, the type II collagen fibrils in cartilage have covalently bound type IX fibril-associated collagens at regular intervals. Other types of fibril-associated collagens are...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Natural Selection and Mating Preferences
Females, due to their biological roles in conception, pregnancy, and nursing,...

